Bandingkan Harga & Kinerja Indo Tambangraya Megah Tbk (ITMG) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Indo Tambangraya Megah Tbk dan Organon Pharma Indonesia Tbk.: Indo Tambangraya Megah Tbk diperdagangkan di Rp26.100 (kapitalisasi pasar 29,49 T, volume 24 jam 1,29 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Indo Tambangraya Megah Tbk jauh lebih besar — sekitar 282,5× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| ITMG | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 29,49 T | 104,4 M |
Volume | 1,29 jt | — |
Lot | 12,91 rb | — |
Perputaran | 33,85 M | — |
Harga Rata-rata | 26.216,62 | — |
Nilai Transaksi | 33,85 M | — |
Harga Ekuilibrium Indikatif | 26.100 | — |
Volume Ekuilibrium Indikatif | 740 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Indo Tambangraya Megah Tbk
PT Indo Tambangraya Megah (the company) was established under its original name of PT Indotambangraya Megah base on notarial deed No.13 of Mr Benny Kristianto, SH, dated on Sep 2, 1987. The Company’s articles of association has been amended several times, most recently by notarial deed No. 33 dated 27 Jul 07 and No. 14 dated 22 Oct 07 of Fathiah Helmi concerning among others, the change in the Capital Structure, par value and public offering.
Selengkapnya di halaman ITMG →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
